What is the share price of KOBO Biotech Ltd (KOBO) today?
The share price of KOBO as on 22nd October 2026 is ₹4.11. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on KOBO Biotech Ltd (KOBO) share?
The past returns of KOBO Biotech Ltd (KOBO) share are- Past 1 week: -7.22%
- Past 1 month: -2.38%
- Past 3 months: -55.62%
- Past 6 months: 44.21%
- Past 1 year: 38.85%
- Past 3 years: 54.51%
- Past 5 years: -27.51%
What are the peers or stocks similar to KOBO Biotech Ltd (KOBO)?
The peers or stocks similar to KOBO Biotech Ltd (KOBO) include:What is the market cap of KOBO Biotech Ltd (KOBO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of KOBO Biotech Ltd (KOBO) is ₹10.36 Cr as of 22nd October 2026.What is the 52 week high and low of KOBO Biotech Ltd (KOBO) share?
The 52-week high of KOBO Biotech Ltd (KOBO) is ₹9.99 and the 52-week low is ₹1.99.What is the PE and PB ratio of KOBO Biotech Ltd (KOBO) stock?
The P/E (price-to-earnings) ratio of KOBO Biotech Ltd (KOBO) is -1.99. The P/B (price-to-book) ratio is -0.08.Which sector does KOBO Biotech Ltd (KOBO) belong to?
KOBO Biotech Ltd (KOBO) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy KOBO Biotech Ltd (KOBO) shares?
You can directly buy KOBO Biotech Ltd (KOBO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
KOBO Biotech Ltd
KOBO Share Price
BSE₹4.111.91% (-0.08)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP
KOBO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
KOBO Performance & Key Metrics
KOBO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -2.06 | -0.08 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.18 | 5.54 | 0.51% |
KOBO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
KOBO Company Profile
Kobo Biotech Limited is an India-based company focused on manufacturing active pharmaceutical ingredients (APIs) and bulk drugs, currently undergoing corporate insolvency resolution.
PE Ratio
36.76
36.76
1Y Return
4.03%
4.03%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
80.16
80.16
1Y Return
27.70%
27.70%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.23
22.23
1Y Return
12.49%
12.49%
Buy Reco %
57.69
57.69
LAURUSLABS
PE Ratio
125.24
125.24
1Y Return
114.31%
114.31%
Buy Reco %
61.54
61.54
CIPLA
PE Ratio
27.60
27.60
1Y Return
19.10%
19.10%
Buy Reco %
62.86
62.86
KOBO Forecast
KOBO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
KOBO
KOBO
Income
Balance Sheet
Cash Flow
Quarterly Normal View
KOBO Income Statement
KOBO Income Statement
Quarterly Normal View
| Quarter | mar 2022 | jun 2022 | sep 2022 | dec 2022 | mar 2023 | jun 2023 | sep 2023 | dec 2023 | mar 2024 | jun 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | ||||||||||
Operating & Other expenses | 9.24 | 0.33 | 0.21 | 0.17 | 0.79 | 0.23 | 0.20 | 0.20 | 0.25 | 0.34 | ||||||||||
EBITDA | -9.24 | -0.31 | -0.21 | -0.17 | -0.79 | -0.21 | -0.20 | -0.20 | -0.25 | -0.32 | ||||||||||
| Depreciation/Amortization | 1.18 | 1.15 | 0.89 | 1.03 | 1.00 | 1.01 | 1.02 | 1.03 | 1.01 | 1.01 | ||||||||||
| PBIT | -10.42 | -1.46 | -1.10 | -1.20 | -1.79 | -1.22 | -1.22 | -1.23 | -1.26 | -1.33 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -10.42 | -1.46 | -1.10 | -1.20 | -1.79 | -1.22 | -1.22 | -1.23 | -1.26 | -1.33 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -10.42 | -1.46 | -1.10 | -1.20 | -1.79 | -1.22 | -1.22 | -1.23 | -1.26 | -1.33 | ||||||||||
| EPS | -4.37 | -0.62 | -0.46 | -0.50 | -0.75 | -0.51 | -0.51 | -0.52 | -0.53 | -0.56 |
KOBO Company Updates
KOBO Stock Peers
KOBO Past Performance & Peer Comparison
KOBO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| KOBO Biotech Ltd | -1.99 | -0.08 | — |
| Sun Pharmaceutical Industries Limited | 36.76 | 5.03 | 0.91% |
| Torrent Pharmaceuticals Ltd | 80.16 | 9.86 | 0.74% |
| Zydus Lifesciences Ltd | 22.23 | 3.79 | 0.09% |
Compare valuation on ScreenerKOBO Stock Price Comparison
Compare KOBO with any stock or ETFCompare KOBO with any stock or ETF
KOBO
KOBO Holdings
KOBO Shareholdings
KOBO Promoter Holdings Trend
KOBO Promoter Holdings Trend
KOBO Institutional Holdings Trend
KOBO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
KOBO Shareholding Pattern
KOBO Shareholding Pattern
KOBO Shareholding History
KOBO Shareholding History
Foreign Institutions
smallcases containing KOBO stock
smallcases containing KOBO stock
Looks like this stock is not in any smallcase yet.
KOBO Events
KOBO Events
KOBO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
KOBO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
KOBO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
KOBO has not given any dividends in last 5 years
KOBO Upcoming Dividends
KOBO Upcoming Dividends
No upcoming dividends are available
KOBO Past Dividends
KOBO Past Dividends
Cash Dividend
Ex DateEx DateSep 21, 2012
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 21, 2012
Cash Dividend
Ex DateEx DateJul 22, 2011
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 22, 2011
KOBO Stock News & Opinions
KOBO Stock News & Opinions
Articles & Videos
Corporate
Corporate
Kobo Biotech confirms XL Softech Systems' compliance with SEBI regulations for Q3 2026Kobo Biotech Limited informed the BSE Limited that XL Softech Systems Ltd. has confirmed compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
1 week agoCapital Market - Live
Corporate
Corporate
Kobo Biotech schedules AGMKobo Biotech announced that the 31th Annual General Meeting(AGM) of the company will be held on 24 July 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Kobo Biotech reports standalone net loss of Rs 1.33 crore in the June 2024 quarterNet Loss of Kobo Biotech reported to Rs 1.33 crore in the quarter ended June 2024 as against net loss of Rs 1.23 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
2 years agoCapital Market - Live
Corporate
Corporate
Kobo Biotech to discuss resultsKobo Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
2 years agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant